Novavax (NVAX) Stock Highlights

8.7 | +0.23%

2024-12-21 04:03:42

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. Novavax develops product candidates geared toward all age demographics of the general population.

Statistics

Range Today

8.37 8.89

Volume Today 6.09M

Range 1 Year

3.53 23.86

Volume 1 Year 2.32B

Range 3 Year

3.53 236.5

Volume 3 Year 5.66B

Range 10 Year

3.53 331.68

Volume 10 Year 9.21B

Highlights

Market Capitalization 1.43B (small)

Floating Shares 143.3M

Current Price 8.7

Price To Earnings -3.63

Price To Revenue 0.65

Earnings Per Share -2.54

Payout Ratio 0%

Performance

Latest +0.23%

1 Month +8.75%

3 Months -30.51%

6 Months -36.4%

1 Year +67.95%

3 Years -96.22%

5 Years +113.24%

10 Years -92.69%

Benchmarks

Market Capitalization

152 / 368

Gross Profits

256 / 278

Total Revenue

17 / 300

Total Rank

6 / 368

Free Cashflow

10 / 352

Performance 5 years

55 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.